The U.S. Preventative Services Task Force (USPSTF) recently released a draft statement assigning a grade A recommendation to screening for human immunodeficiency virus (HIV) in the general population 15 to 65 years of age.
Over the past few decades, one of the most perplexing questions in global health is how to stop HIV.
There have been campaigns involving condoms, abstinence and even the circumcision of all men younger than 46. But one relatively new strategy, called treatment as prevention, is causing quite a buzz.
The U.S. Preventive Services Task Force (USPSTF) is poised to release recommendations on screening for human immunodeficiency virus (HIV) infection that will endorse the routine testing of adults and adolescents, a position first adopted by the Centers for Disease Control and Prevention (CDC) in 2006.
Of the more than 1 million people in the U.S. infected with HIV, nearly half are black men, women and children — even though blacks make up about 13 percent of the population.
In early 1981, when I was designated as surgeon general, I had never heard about AIDS. No one had heard about AIDS, and the handful of scientists who knew about immunodeficiency didn’t even know what to call it, much less what it really was. AIDS entered the consciousness of the public health service quietly, gradually, and without fanfare.